^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
vibostolimab/pembrolizumab (MK-7684A)
i
Other names: MK-7684A, MK-7684/MK-3475, MK7684A, MK 7684A, MK7684/MK3475, MK 7684/MK 3475
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Merck (MSD)
Drug class:
PD1 inhibitor, TIGIT inhibitor
Related drugs:
